Yusuke Shibuya - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yusuke Shibuya

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

The Tohoku Journal of Experimental Medicine|March 22, 2022

MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 ExpressionShogo Shigeta, Yoh Watanabe, Fumihiko Suzuki, et al.

Cancer Gene Therapy|February 29, 2024

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancerKei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, et al.

Cancers|February 25, 2023

SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine SignalingYusuke Shibuya, Kei Kudo, Kristen P Zeligs, et al.

Cancer & Metabolism|October 11, 2023

Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profilingEiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.

Cancers|December 18, 2020

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian CancerAnne M Noonan, Amanda Cousins, David Anderson, et al.

Cell Death & Disease|April 25, 2025

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Yoshimi Endo Greer, Daniel R Crooks, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

The Tohoku Journal of Experimental Medicine|March 22, 2022

MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 ExpressionShogo Shigeta, Yoh Watanabe, Fumihiko Suzuki, et al.

Cancer Gene Therapy|February 29, 2024

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancerKei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, et al.

Cancers|February 25, 2023

SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine SignalingYusuke Shibuya, Kei Kudo, Kristen P Zeligs, et al.

Cancer & Metabolism|October 11, 2023

Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profilingEiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.

Cancers|December 18, 2020

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian CancerAnne M Noonan, Amanda Cousins, David Anderson, et al.

Cell Death & Disease|April 25, 2025

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Yoshimi Endo Greer, Daniel R Crooks, et al.

Pageof 4